Clinical trial NCT04959578 - References

Anemia of Chronic Kidney Disease — Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease

Citation(s)

•   Chavers BM, Herzog CA
  The spectrum of cardiovascular disease in children with predialysis chronic kidney disease. Adv Chronic Kidney Dis. 2004 Jul;11(3):319-27. Review.
•   Gerson A, Hwang W, Fiorenza J, Barth K, Kaskel F, Weiss L, Zelikovsky N, Fivush B, Furth S
  Anemia and health-related quality of life in adolescents with chronic kidney disease. Am J Kidney Dis. 2004 Dec;44(6):1017-23.
•   Klang B, Björvell H, Clyne N
  Quality of life in predialytic uremic patients. Qual Life Res. 1996 Feb;5(1):109-16.
•   Koshy SM, Geary DF
  Anemia in children with chronic kidney disease. Pediatr Nephrol. 2008 Feb;23(2):209-19. Epub 2007 Jan 24. Review.
•   Lerner G, Kale AS, Warady BA, Jabs K, Bunchman TE, Heatherington A, Olson K, Messer-Mann L, Maroni BJ
  Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease. Pediatr Nephrol. 2002 Nov;17(11):933-7. Epub 2002 Sep 14.
•   Ma JZ, Ebben J, Xia H, Collins AJ
  Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol. 1999 Mar;10(3):610-9.
•   Mitsnefes MM, Daniels SR, Schwartz SM, Meyer RA, Khoury P, Strife CF
  Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol. 2000 Sep;14(10-11):898-902.
•   Pattaragarn A, Warady BA, Sabath RJ
  Exercise capacity in pediatric patients with end-stage renal disease. Perit Dial Int. 2004 May-Jun;24(3):274-80.
•   Pickett JL, Theberge DC, Brown WS, Schweitzer SU, Nissenson AR
  Normalizing hematocrit in dialysis patients improves brain function. Am J Kidney Dis. 1999 Jun;33(6):1122-30.
•   Sietsema KE, Hiatt WR, Esler A, Adler S, Amato A, Brass EP
  Clinical and demographic predictors of exercise capacity in end-stage renal disease. Am J Kidney Dis. 2002 Jan;39(1):76-85.
•   VanDeVoorde RG, Warady BA
  Management of chronic kidney disease. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N (eds). Pediatric Nephrology, 6th edn. Springer-Verlag, Berlin, 2009; 1661-92.
•   Warady BA, Arar MY, Lerner G, Nakanishi AM, Stehman-Breen C
  Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease. Pediatr Nephrol. 2006 Aug;21(8):1144-52. Epub 2006 May 25.
•   Warady BA, Ho M
  Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr Nephrol. 2003 Oct;18(10):1055-62. Epub 2003 Jul 23.
•   Xia H, Ebben J, Ma JZ, Collins AJ
  Hematocrit levels and hospitalization risks in hemodialysis patients. J Am Soc Nephrol. 1999 Jun;10(6):1309-16.

Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin as Erythropoietic Agents for Treatment of Anemia in Pediatric Chronic Kidney Disease Patients

Details for clinical trial NCT04959578